Free Trial

agilon health (NYSE:AGL) Trading Up 5.6% - What's Next?

agilon health logo with Medical background

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) rose 5.6% during trading on Monday . The stock traded as high as $4.21 and last traded at $4.23. Approximately 1,546,477 shares changed hands during mid-day trading, a decline of 68% from the average daily volume of 4,772,640 shares. The stock had previously closed at $4.00.

Analyst Ratings Changes

A number of equities research analysts recently commented on AGL shares. Royal Bank of Canada raised their price objective on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Stifel Nicolaus raised their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Robert W. Baird dropped their price objective on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Sanford C. Bernstein upgraded agilon health from a "market perform" rating to an "outperform" rating and boosted their price target for the company from $3.30 to $8.50 in a report on Tuesday, April 8th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, agilon health presently has a consensus rating of "Hold" and an average target price of $4.81.

View Our Latest Research Report on agilon health

agilon health Price Performance

The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company's 50 day moving average is $4.19 and its 200-day moving average is $3.14. The stock has a market cap of $1.61 billion, a PE ratio of -4.14 and a beta of 0.38.

Hedge Funds Weigh In On agilon health

A number of institutional investors have recently made changes to their positions in AGL. JPMorgan Chase & Co. increased its holdings in shares of agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after acquiring an additional 1,083,492 shares during the last quarter. Inspire Investing LLC boosted its position in agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock worth $413,000 after acquiring an additional 112,241 shares during the period. Geode Capital Management LLC increased its stake in agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after buying an additional 35,207 shares during the period. KLP Kapitalforvaltning AS bought a new stake in agilon health during the fourth quarter worth approximately $111,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of agilon health in the fourth quarter valued at $33,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Recommended Stories

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines